Human mesenchymal stromal cell lysates as a novel strategy to recover liver function

Regen Med. 2015;10(1):25-38. doi: 10.2217/rme.14.59.

Abstract

Aim: It is unknown if the beneficial effects of mesenchymal stromal cells (MSC) transplantation into the liver are dependent on their anchorage and differentiation into hepatocytes or rather the result of the release of stem cell intracellular content with hepatoprotector properties.

Materials & methods: The effects of intact MSC transplantation were compared with the infusion of MSC lysates in an experimental rat model of acute liver failure.

Results: A more powerful hepatoprotective and antiapoptotic effect was obtained after infusion of MSC lysates than intact MSC. Changes in IL-6 levels and miRNAs might explain the beneficial effects of MSC lysates.

Conclusion: Infusion of MSC lysates show a better hepatoprotective effect than the transplantation of intact MSC.

Keywords: acute liver failure; apoptosis; cell lysates; cell therapy; mesenchymal stromal cells.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Extracts / pharmacology*
  • Cell Extracts / therapeutic use*
  • Cell Proliferation / drug effects
  • Cytokines / metabolism
  • Female
  • Humans
  • Immunophenotyping
  • Liver / drug effects
  • Liver / physiology*
  • Liver Diseases / pathology
  • Liver Diseases / therapy
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells / cytology*
  • MicroRNAs / metabolism
  • Pluripotent Stem Cells / cytology
  • Portal Vein / physiology
  • Rats, Wistar
  • Thioacetamide / administration & dosage
  • Thy-1 Antigens / metabolism

Substances

  • Cell Extracts
  • Cytokines
  • MicroRNAs
  • Thy-1 Antigens
  • Thioacetamide